\-\ Texto\\:\\ \ \(0\)\
\-\ alk\\ phos\\ \\-\\ 210\ \(0\)\
\-\ ast\\/alt\\-\\ 17\\/132\ \(0\)\
\-\ tb\\ \\-\\ 21\\.7\ \(0\)\
\-\ db\\ \\-\\ 12\\.8\ \(0\)\
\-\ ammonia\\-\\ 45\ \(0\)\
\-\ the\\ patient\\ expired\\ secondary\\ to\\ his\\ metastatic\\ pancreatic\\ cancer\\.\ \(0\)\
\-\ single\\ contrast\\ enhanced\\ axial\\ image\\ at\\ the\\ level\\ of\\ the\\ kidneys\\ demonstrates\\ air\\ within\\ the\\ biliary\\ system\\.\\ \\ also\\ identified\\ is\\ a\\ biliary\\ stent\\.\\ no\\ significant\\ biliary\\ dilitation\\ is\\ noted\\.\ \(0\)\
\-\ pneumobilia\ \(2\)\
\-\ portal\\ venous\\ gas\\ vs\\.\\ biliary\\ gas\ \(0\)\
\-\ portal\\ venous\\ gas\\ tends\\ to\\ extend\\ to\\ the\\ periphery\\ of\\ the\\ liver\\ as\\ opposed\\ to\\ biliary\\ air\\ which\\ is\\ more\\ central\\ in\\ its\\ location\ \(0\)\
\-\ 82\\ y\\/o\\ male\\ with\\ pancreatic\\ cancer\\ and\\ biliary\\ obstruction\\ who\\ is\\ status\\ post\\ biliary\\ stent\\ placement\\ in\\ xs\\ 2\\ in\\ 2002\\ who\\ presents\\ with\\ reobstruction\\ of\\ the\\ biliary\\ tree\\.\\ \\ exam\\ performed\\ to\\ evaluate\\ tumor\\ progression\\ and\\ extent\\ of\\ involvement\\ in\\ the\\ biliary\\ tree\\.\ \(0\)\
\-\ when\\ air\\ is\\ present\\ in\\ the\\ biliary\\ tree\\ on\\ radiographic\\ examination\\ thought\\ should\\ be\\ given\\ to\\ whether\\ the\\ patient\\ has\\ had\\ surgery\\ or\\ other\\ procedure\\ involving\\ the\\ biliary\\ tree\\.\\ \\ this\\ can\\ cause\\ abnormal\\ communication\\ between\\ the\\ biliary\\ tree\\ and\\ the\\ bowel\\ therefore\\ allowing\\ air\\ into\\ the\\ biliary\\ system\\.\ \(0\)\
\-\ patients\\ with\\ penetrating\\,\\ gallstones\\,\\ crohn\\'s\\ disease\\,\\ some\\ malignancies\\ and\\ duodenal\\ ulcers\\ are\\ prone\\ to\\ pneumobilia\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ biliary\\:\\ 0\\.2763754374249805\ \(0\)\
\-\ tree\\:\\ 0\\.1250701676276633\ \(0\)\
\-\ pneumobilia\\:\\ 0\\.07602863187486097\ \(0\)\
\-\ gas\\:\\ 0\\.0601564477182746\ \(0\)\
\-\ air\\:\\ 0\\.05697069214880721\ \(0\)\
\-\ stent\\:\\ 0\\.04737128314023672\ \(0\)\
\-\ portal\\:\\ 0\\.04431556956088856\ \(0\)\
\-\ 17\\/132\\:\\ 0\\.04342619913283989\ \(0\)\
\-\ ammonia\\-\\:\\ 0\\.04342619913283989\ \(0\)\
\-\ xs\\:\\ 0\\.04342619913283989\ \(0\)\
\-\ reobstruction\\:\\ 0\\.04342619913283989\ \(0\)\
\-\ pancreatic\\:\\ 0\\.04119004370184101\ \(0\)\
\-\ ast\\/alt\\-\\:\\ 0\\.040011681002002725\ \(0\)\
\-\ 21\\.7\\:\\ 0\\.040011681002002725\ \(0\)\
\-\ 210\\:\\ 0\\.03801431593743049\ \(0\)\
\-\ db\\:\\ 0\\.03659716287116555\ \(0\)\
\-\ 12\\.8\\:\\ 0\\.035497933554346786\ \(0\)\
\-\ system\\:\\ 0\\.0331475859152788\ \(0\)\
\-\ venous\\:\\ 0\\.030559464221252504\ \(0\)\
\-\ dilitation\\:\\ 0\\.028428551656369826\ \(0\)\
\-\ expired\\:\\ 0\\.028199389017774298\ \(0\)\
\-\ tends\\:\\ 0\\.027770761544918976\ \(0\)\
\-\ cancer\\:\\ 0\\.027676505067633157\ \(0\)\
\-\ opposed\\:\\ 0\\.02719054954661167\ \(0\)\
\-\ allowing\\:\\ 0\\.02719054954661167\ \(0\)\
\-\ \\-\\:\\ 0\\.027069878700123597\ \(0\)\
\-\ malignancies\\:\\ 0\\.026838534945714403\ \(0\)\
\-\ 82\\:\\ 0\\.026054965021430232\ \(0\)\
\-\ gallstones\\:\\ 0\\.02563842616414913\ \(0\)\
\-\ prone\\:\\ 0\\.025254379161835278\ \(0\)\
\-\ penetrating\\:\\ 0\\.02478487088693713\ \(0\)\
\-\ ulcers\\:\\ 0\\.02478487088693713\ \(0\)\
\-\ communication\\:\\ 0\\.024674167163527973\ \(0\)\
\-\ alk\\:\\ 0\\.024565896687080806\ \(0\)\
\-\ phos\\:\\ 0\\.024565896687080806\ \(0\)\
\-\ periphery\\:\\ 0\\.02350969042429531\ \(0\)\
\-\ 2002\\:\\ 0\\.023016668460960423\ \(0\)\
\-\ duodenal\\:\\ 0\\.023016668460960423\ \(0\)\
\-\ whether\\:\\ 0\\.022640446890593063\ \(0\)\
\-\ crohn\\:\\ 0\\.02249765114244896\ \(0\)\
\-\ who\\:\\ 0\\.021950427676272928\ \(0\)\
\-\ extend\\:\\ 0\\.02109812281188789\ \(0\)\
\-\ progression\\:\\ 0\\.02094172528324464\ \(0\)\
\-\ extent\\:\\ 0\\.020890677071246876\ \(0\)\
\-\ tb\\:\\ 0\\.02027112343928119\ \(0\)\
\-\ therefore\\:\\ 0\\.019883718871206744\ \(0\)\
\-\ 45\\:\\ 0\\.019448196913846874\ \(0\)\
\-\ kidneys\\:\\ 0\\.019372987691527722\ \(0\)\
\-\ thought\\:\\ 0\\.019372987691527722\ \(0\)\
\-\ enhanced\\:\\ 0\\.018012133619467827\ \(0\)\
\-\ procedure\\:\\ 0\\.017630918527766253\ \(0\)\
\-\ placement\\:\\ 0\\.017085767947039553\ \(0\)\
\-\ single\\:\\ 0\\.017062365963007052\ \(0\)\
\-\ evaluate\\:\\ 0\\.017015892897818092\ \(0\)\
\-\ vs\\:\\ 0\\.0165737929576394\ \(0\)\
\-\ radiographic\\:\\ 0\\.015977164491570117\ \(0\)\
\-\ its\\:\\ 0\\.015884391347072126\ \(0\)\
\-\ involvement\\:\\ 0\\.015428269244472003\ \(0\)\
\-\ identified\\:\\ 0\\.015041709562494194\ \(0\)\
\-\ status\\:\\ 0\\.015026242961485978\ \(0\)\
\-\ obstruction\\:\\ 0\\.014844335214726284\ \(0\)\
\-\ involving\\:\\ 0\\.014770479133021151\ \(0\)\
\-\ to\\:\\ 0\\.014726486498034009\ \(0\)\
\-\ location\\:\\ 0\\.014683289098048734\ \(0\)\
\-\ liver\\:\\ 0\\.014513406457304057\ \(0\)\
\-\ given\\:\\ 0\\.014430612771016465\ \(0\)\
\-\ cause\\:\\ 0\\.014242673037201803\ \(0\)\
\-\ central\\:\\ 0\\.013850400772709158\ \(0\)\
\-\ is\\:\\ 0\\.01384952656120014\ \(0\)\
\-\ should\\:\\ 0\\.013419746511767488\ \(0\)\
\-\ between\\:\\ 0\\.01334234254297657\ \(0\)\
\-\ post\\:\\ 0\\.01325534499050391\ \(0\)\
\-\ bowel\\:\\ 0\\.013201741541304234\ \(0\)\
\-\ image\\:\\ 0\\.013148715104914289\ \(0\)\
\-\ examination\\:\\ 0\\.01308582776095845\ \(0\)\
\-\ some\\:\\ 0\\.012782897802299307\ \(0\)\
\-\ his\\:\\ 0\\.0121324582642706\ \(0\)\
\-\ level\\:\\ 0\\.0121324582642706\ \(0\)\
\-\ when\\:\\ 0\\.012055818904512343\ \(0\)\
\-\ axial\\:\\ 0\\.012013751113634836\ \(0\)\
\-\ abnormal\\:\\ 0\\.012005380494162126\ \(0\)\
\-\ secondary\\:\\ 0\\.011768620524673928\ \(0\)\
\-\ performed\\:\\ 0\\.011736839070085315\ \(0\)\
\-\ y\\/o\\:\\ 0\\.011658271082855373\ \(0\)\
\-\ significant\\:\\ 0\\.011319444093863169\ \(0\)\
\-\ patients\\:\\ 0\\.010894456154512443\ \(0\)\
\-\ metastatic\\:\\ 0\\.010596598047369904\ \(0\)\
\-\ more\\:\\ 0\\.010527962114838257\ \(0\)\
\-\ in\\:\\ 0\\.010379242121681157\ \(0\)\
\-\ surgery\\:\\ 0\\.010221670267784606\ \(0\)\
\-\ into\\:\\ 0\\.010016386049062596\ \(0\)\
\-\ noted\\:\\ 0\\.009977444278091595\ \(0\)\
\-\ tumor\\:\\ 0\\.009813952224683798\ \(0\)\
\-\ other\\:\\ 0\\.009702652949273145\ \(0\)\
\-\ can\\:\\ 0\\.009547893361916599\ \(0\)\
\-\ the\\:\\ 0\\.009534433427836261\ \(0\)\
\-\ present\\:\\ 0\\.009507432285377738\ \(0\)\
\-\ contrast\\:\\ 0\\.009422540329102983\ \(0\)\
\-\ \\'s\\:\\ 0\\.009281017824468203\ \(0\)\
\-\ exam\\:\\ 0\\.009247457832263734\ \(0\)\
\-\ demonstrates\\:\\ 0\\.009195178333266926\ \(0\)\
\-\ had\\:\\ 0\\.009083004035668514\ \(0\)\
\-\ 2\\:\\ 0\\.009064554170002691\ \(0\)\
\-\ presents\\:\\ 0\\.008599232982797664\ \(0\)\
\-\ patient\\:\\ 0\\.008439329368634365\ \(0\)\
\-\ also\\:\\ 0\\.008298618688030302\ \(0\)\
\-\ within\\:\\ 0\\.008030203982197446\ \(0\)\
\-\ has\\:\\ 0\\.007904925963026\ \(0\)\
\-\ which\\:\\ 0\\.007857855109569205\ \(0\)\
\-\ male\\:\\ 0\\.00761184994033238\ \(0\)\
\-\ disease\\:\\ 0\\.006880480498599528\ \(0\)\
\-\ be\\:\\ 0\\.006491412430265661\ \(0\)\
\-\ as\\:\\ 0\\.0063673768763257525\ \(0\)\
\-\ are\\:\\ 0\\.005738294938569467\ \(0\)\
\-\ at\\:\\ 0\\.005703266762717404\ \(0\)\
\-\ or\\:\\ 0\\.004933609600806441\ \(0\)\
\-\ this\\:\\ 0\\.004734666075439079\ \(0\)\
\-\ no\\:\\ 0\\.004238641136471931\ \(0\)\
\-\ \\,\\:\\ 0\\.004000641362324444\ \(0\)\
\-\ on\\:\\ 0\\.0035659655781548182\ \(0\)\
\-\ and\\:\\ 0\\.0035469754824082452\ \(0\)\
\-\ of\\:\\ 0\\.0022956413950342546\ \(0\)\
\-\ a\\:\\ 0\\.00195369360501774\ \(0\)\
\-\ \\.\\:\\ 0\\.0017487456205589299\ \(0\)\
\-\ with\\:\\ 0\\.001729125755023001\ \(0\)\
